TMED3 and glioblastoma: Through bioinformatics analysis and single-cell sequencing of GBM and adjacent normal tissue samples, we found that TMED3 is highly expressed in GBM, and patients with low TMED3 expression exhibited better DFS and OS compared to those with high TMED3 expression.